TLS Online TPP Program

#Question id: 2114


A research team is working on the design of a new drug for the treatment of lung cancer. To be most effective, this drug must specifically enter the cytoplasm of lung cells while not entering the cells of other tissues. Which of the following characteristics would likely enhance the specificity of this drug?

#Unit 2. Cellular Organization
  1. the relative hydrophobicity of the drug molecule

  2. phospholipid composition of lung cell plasma membranes

  3. specificity of the drug molecule for binding to the extracellular matrix of lung cells

  4. similarity of the drug molecule to other molecules normally transported lung cells

More Questions
TLS Online TPP Program

#Question id: 1134

#Unit 4. Cell Communication and Cell Signaling

Arrange the following proteins in the proper order in which they become activated in the MAPK signaling pathway:

a. MAP kinase                         b. MEK           c. Ras              d. Raf              e. RTK            

TLS Online TPP Program

#Question id: 1135

#Unit 4. Cell Communication and Cell Signaling

Which of the following is a direct substrate of MAP kinase?

a. TCF             b. SRF             c. SRE             d. p90RSK      e. CREB

TLS Online TPP Program

#Question id: 1136

#Unit 4. Cell Communication and Cell Signaling

Which of the following signaling pathways can be activated by activation of receptor tyrosine kinases?

a. phospholipase Cγ                b. PI-3 kinase

c. MAP kinase                         d. none of the above

TLS Online TPP Program

#Question id: 1137

#Unit 4. Cell Communication and Cell Signaling

A loss-of-function mutation in PTEN phosphatase results in

a. increased cell proliferation.            

b. decreased cell proliferation.

c. increased apoptosis.                                   

d. decreased apoptosis.

TLS Online TPP Program

#Question id: 1138

#Unit 4. Cell Communication and Cell Signaling

A loss-of-function mutation in Wnt would have a phenotype similar to a

a. gain-of-function mutation in GSK-3.                    

b. gain-of-function mutation in β-catenin.

c. loss-of-function mutation in GSK-3.                     

d. loss-of-function mutation in β-catenin.

TLS Online TPP Program

#Question id: 1139

#Unit 4. Cell Communication and Cell Signaling

In paracrine signaling, the signaling molecule: